Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;1(1):e22.
doi: 10.1002/cpz1.22.

Chemical Synthesis of a Locked Nucleic Acid-Substituted Dinucleotide Cap Analog

Muthian Shanmugasundaram  1 , Annamalai Senthilvelan  1 , Anilkumar R Kore  1
Affiliations

Chemical Synthesis of a Locked Nucleic Acid-Substituted Dinucleotide Cap Analog

Muthian Shanmugasundaram et al. Curr Protoc. 2021 Jan.

Erratum in

Abstract

This article describes a reliable and efficient method for synthesis of the dinucleotide cap analog m7(LNA) G[5']ppp[5']G containing a locked nucleic acid moiety. The required LNA intermediate for the final coupling reaction, m7(LNA) GDP, is prepared in six steps starting from 5'-DMTr-N-DMF LNA guanosine. The overall reaction involves removal of DMTr and DMF groups, 5' monophosphorylation, imidazolide formation, diphosphorylation, and regioselective m7 methylation. The final coupling reaction of m7(LNA) GDP with ImGMP in the presence of zinc chloride as a catalyst affords m7(LNA) G[5']ppp[5']G in 59% yield. © 2021 Wiley Periodicals LLC. Basic Protocol: Synthesis of an LNA-substituted dinucleotide cap analog Support Protocol: Preparation of the tris(tributylammonium) phosphate linker.

Keywords: 7-methylguanosine; anti-reverse cap analog; eukaryotic mRNA; locked nucleic acid; regioselective.

PubMed Disclaimer

References

Literature Cited

    1. Jemielity, J., Fowler, T., & Zuberek, J. (2003). Novel "anti-reverse" cap analogs with superior translational properties. RNA, 9, 1108-1122. doi: 10.1261/rna.5430403.
    1. Jepsen, J. S., Sørensen, M. D., & Wengel, J. (2004). Locked nucleic acid: A potent nucleic acid analog in therapeutics and biotechnology. Oligonucleotides, 14, 130-146. doi: 10.1089/1545457041526317.
    1. Jia, Y., Polunovsky, V., Bitterman, P. B., & Wagner, C. R. (2012). Cap-dependent translation initiation factor eIF4E: An emerging anticancer drug target. Medicinal Research Reviews, 32, 786-814. doi: 10.1002/med.21260.
    1. Kadokura, M., Wada, T., & Urashima, C. (1997). Efficient synthesis of γ-methyl-capped guanosine 5′-triphosphate as a 5′-terminal unique structure of U6 RNA via a new triphosphate bond formation involving activation of methyl phosphorimidazolidate using ZnCl2 as a catalyst in DMF under anhydrous conditions. Tetrahedron Letters, 38, 8359-8362. doi: 10.1016/S0040-4039(97)10263-5.
    1. Kore, A. R., Charles, I., & Shanmugasundaram, M. (2008). Recent developments in 5-terminal cap analogs: Synthesis and biological ramifications. Mini-Reviews in Organic Chemistry, 5, 179-192. doi: 10.2174/157019308785161666.

LinkOut - more resources